Iatrogenic subretinal injection of Ozurdex® implant and its effect on macular edema
PURPOSE: The purpose of this study was to report a rare case of subretinal lodgement of Ozurdex® implant (Allergan Inc., Irvine, CA, USA) and its effect on macular edema in a case of central retinal vein occlusion (RVO). METHODS: A rare complication of subretinal lodgement of Ozurdex® implant withou...
Main Authors: | Smita Shriram Karandikar, George J Manayath, Veerappan Saravanan, Siddharth Narendran, Venkatapathy Narendran |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Oman Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ojoonline.org/article.asp?issn=0974-620X;year=2017;volume=10;issue=2;spage=100;epage=102;aulast=Karandikar |
Similar Items
-
To study the effect of intravitreal ozurdex implant in cases of retinal vein occlusion
by: Shailender K Chaudhary, et al.
Published: (2022-01-01) -
Efficacy of Intravitreal Dexamethasone Implant in Different Patterns of Diabetic Macular Edema
by: Claudio Furino, et al.
Published: (2020-10-01) -
Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
by: Verónica Castro-Navarro, et al.
Published: (2019-01-01) -
Active removal of anterior segment-migrated dexamethasone implant (Ozurdex)
by: Depla, Jozef Adelson M., et al.
Published: (2022-03-01) -
Ozurdex completely located inside a crystallized lens - Results of 14 months
by: Burhan Baskan, et al.
Published: (2016-12-01)